-
Mashup Score: 18Alcohol consumption and progression of heart failure in those at risk for or with pre-heart failure - 8 month(s) ago
People with heart risk factors such as high blood pressure, diabetes, obesity or high cholesterol, may develop extra strain on the heart over time because of these risk factors. We researched the association of low and moderate-high levels of alcohol intake, compared to no intake, with changes in the heart over time. We found that amongst participants with heart abnormalities, drinking the equivalent of more than a bottle of wine per week was associated with further negative changes in the heart or development of symptoms of heart failure.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 28My Journey as a Heart Transplantation Patient…and What I Want Providers to Know: Part 1 - 8 month(s) ago
JCF is honored to share this Patient Experience Series over the next 3 weeks. Part I is below. The full story will be published in the May 2024 issue and online under our Patient and Caregiver Center at www.jcfonline.com.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
This month, #JCF is sharing the story of a patient’s journey to 🫀 transplantation – written from the patient's perspective! A husband, a new father, a professional athlete ... & now a patient. Read part 1 of this powerful 3-part series, out now ⬇️ 🔗https://t.co/4noD6CXgz5 https://t.co/h65P2RCHhK
-
-
Mashup Score: 54Sodium-Glucose Co-transporter 2 Inhibitors and Mycotic Genital or Urinary Tract Infections in Heart Failure - 8 month(s) ago
Sodium-glucose co-transporter 2 (SGLT2) inhibitors have proven benefits on clinical outcomes in patients with heart failure (HF).1-6 However, this class of medications increases the risk of mycotic genital infections (MGIs) and urinary tract infections (UTIs), particularly within the first 3-6 months after their initiation.7,8,9 In the EMPEROR-Preserved and EMPEROR-Reduced trials, MGIs and UTIs were among the 3 most common adverse events in the empagliflozin group,1,2 highlighting the clinical relevance of these infections.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
SLGT2i have revolutionized #FunctionNotFailure Care across EF, DM, and acute/chronic settings.🫀 What about infectious risk? How often? In whom? When to avoid? Hold? Practical considerations here in this ⭐ review by @AngelaDuvalyan and Dr. Mark Drazner: https://t.co/v52DcosNbF https://t.co/mP7UGTfGQh
-
-
Mashup Score: 41The Future of Durable Mechanical Circulatory Support: Emerging Technological Innovations and Considerations to Enable Evolution of the Field - 8 month(s) ago
The field of durable mechanical circulatory support (MCS) has undergone an incredible evolution over the past few decades, resulting in significant improvements in longevity and quality of life for patients with advanced heart failure. Despite these successes, substantial opportunities for further improvements remain, including in pump design and ancillary technology, perioperative and postoperative management, and the overall patient experience. Ideally, durable MCS devices would be fully implantable, automatically controlled, and minimize the need for anticoagulation.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
🔥 Out now in our April issue! 🌸 A State of the Art Review on Durable MCS devices by @DualSeraina & colleagues. Everything you need to know, including unmet needs, emerging technologies & the future of MCS. 🔗 https://t.co/38UuKZSqU6 https://t.co/Dh5zddJ9eA
-
-
Mashup Score: 37Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis - 8 month(s) ago
Consensus recommendations for cardiogenic shock (CS) advise transfer of patients in need of advanced options beyond the capability of “spoke” centers to tertiary/“hub” centers with higher capabilities. However, outcomes associated with such transfers are largely unknown beyond those reported in individual health networks.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
🫀In this #CardiogenicShock study, over 1/2 of CS pts at large hubs had been transferred from other hospitals. They had higher mortality compared to those presenting directly to the hub & this was primarily driven by pts with HF-CS rather than AMI-CS. 🔗https://t.co/JwAsnJrCoN https://t.co/l3sz2sKP44
-
-
Mashup Score: 32Changing Strategy Between Bridge to Transplant and Destination LVAD Therapy After the First 3 Months: Analysis of the STS-INTERMACS Database - 8 month(s) ago
Left ventricular assist devices (LVADs) have been implanted as bridge to transplantation (BTT), bridge to candidacy (BTC) or destination therapy (DT) on the basis of relative and absolute contraindications to transplantation. Multiple factors may lead to changes in the strategy of support after LVAD implantation.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
⚙️⏰ #LVAD implant strategies change over time due to pre-implant factors & post-implant complications. In this STS-INTERMACS database analysis, @aniket_rali & colleagues identify factors associated with a switch from BTT to DT strategy & vice versa. 🔗https://t.co/kA57cJcfOo https://t.co/vHSvAe7uxP
-
-
Mashup Score: 24The impact of local programmatic decisions on outcomes in transplant-listed adults with congenital heart disease - 8 month(s) ago
Heart failure is the leading cause of death for adults with congenital heart disease (ACHD), complicated by unclear efficacy of guideline-directed medical therapy in this population1–3 and a lack of consensus on appropriate timing for orthotopic heart transplant (OHT) referral.4 Once referred for transplant, the path remains unclear for these patients, as it has been previously shown that ACHD heart transplant candidates experienced longer wait times and higher waitlist mortality than non-ACHD candidates.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
🔥New science alert! Compared to others, how do #ACHD pts do on the 🫀 transplant waitlist? @armaan_akbar et al set out to answer this question in their retrospective analysis of #UNOS data, out now in #JCF! #ISHLT2024 🔗 https://t.co/IHaSnoPdQm https://t.co/6Jic9ucVbw
-
-
Mashup Score: 19
Traditional randomized controlled trials (RCTs) are necessary for establishing causality between interventions and outcomes, forming the basis for clinical guidelines.1 However, the requirement for study-specific in-person study visits by participants to collect accurate clinical outcomes poses a burden on participants and sites, resulting in high costs and limiting eligible participants to those with the ability to travel to visits.2 Remote follow-up methods, such as utilizing central call centers for participant-reported events or site reports using medical record query, have potential for enhanced trial efficiency, reduced costs, and less burden on both participants and clinical trial sites.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
Out now in #JCF! Remote follow-up visits can reduce costs & enhance pragmatic HF trials. In this analysis of CONNECT-HF, @SS_cardiol et al. evaluated the completeness & validity of the remote follow-ups. #ACC 🔗: https://t.co/ZXMjLlZFhj https://t.co/pAUR5vHhSu
-
-
Mashup Score: 29The Wallet Biopsy: Medical Crowdfunding for Heart Transplantation - 9 month(s) ago
Financial considerations continue to impact access to heart transplantation. Transplant recipients face various costs, including, but not limited to, the index hospitalization, immunosuppressive medications, and lodging and travel to appointments. In this study, we sought to describe the state of crowdfunding for individuals being evaluated for heart transplantation. Using the search term heart transplant, 1000 GoFundMe campaigns were reviewed. After exclusions, 634 (63.4%) campaigns were included.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
🫀 Transplantation comes with many 💰 burdens for patients. In this analysis, the authors evaluated crowdfunding campaigns for HT-related costs, & found racial & gender biases. Advocacy efforts are needed to improve access to HT! #ACC #JCF 🔗: https://t.co/WdYO97Ob3k https://t.co/w0vCbBzJgK
-
-
Mashup Score: 0Journal of Cardiac Failure | LinkedIn - 9 month(s) ago
Journal of Cardiac Failure | 4 followers on LinkedIn. From Function to Failure | The official Journal of the Heart Failure Society of America and the Japanese Heart Failure Society🫀 The Journal of Cardiac Failure publishes the highest quality science in the field of heart failure with a focus on diversity, equity, and inclusion, mentorship, multidisciplinary partnerships, and patient-centeredness. Published papers span original investigator-initiated work to state-of-the-art reviews, guidelines and scientific statements, expert perspectives, early career and trainee spotlight pieces, and patient and patient-partner narratives. JCF emphasizes the power of language and prioritizes innovative approaches to the dissemination of published work to reach and impact the broader heart failure community.
Source: www.linkedin.comCategories: General Medicine News, Partners & KOLsTweet-
Now, you can access #JCF everywhere! 🎉🫀 Follow us on LinkedIn, Instagram, and Facebook to stay up-to-date with the latest research and news in the field of heart failure! LI: https://t.co/argvofvEPX IG: https://t.co/hCSPRPCebT FB: https://t.co/5d38JHTCNq https://t.co/zdvkn0iWIh
-
🚨Attention patients and clinicians!🚨 New research suggests that consuming more than 70g of alcohol per week may put individuals with pre-HF at an increased risk of heart failure progression. The risk remains when heavy alcohol intake is excluded. 🔗 https://t.co/pU3dX3GpoY https://t.co/T087gpn9b2